Drug interactions
Cabazitaxel + Meningococcal group b vaccine
Severity: Moderate
Cabazitaxel and Meningococcal group b vaccine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Chemotherapy-induced myelosuppression may blunt the antibody response to this non-live vaccine. The vaccine is not unsafe, but protection may be inadequate.
What this interaction means in plain words
Cabazitaxel and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Cytotoxic immunosuppression reduces vaccine immunogenicity.
What to do
Where possible, vaccinate at least two weeks before starting chemotherapy or after immune recovery; revaccinate if given during treatment and indicated.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cabazitaxel and Meningococcal group b vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Cabazitaxel
Frequently asked questions
Can I take Cabazitaxel with Meningococcal group b vaccine?
MediHelp rates the interaction as moderate. Cabazitaxel and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Chemotherapy-induced myelosuppression may blunt the antibody response to this non-live vaccine. The vaccine is not unsafe, but protection may be inadequate.
How serious is the interaction between Cabazitaxel and Meningococcal group b vaccine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, vaccinate at least two weeks before starting chemotherapy or after immune recovery; revaccinate if given during treatment and indicated.
What other medicines interact with Cabazitaxel?
MediHelp also lists interactions of Cabazitaxel with, for example, Adenovirus types 4 and 7 live, Atazanavir, Bcg intravesical live. The full list is on the Cabazitaxel page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
